खोज परिणाम - Sarah Oelsner

  • प्रदर्शित 1 - 5 परिणाम 5
परिणाम को परिष्कृत करें
  1. 1
    Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity

    Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity द्वारा Congcong Zhang, Pranav Oberoi, Sarah Oelsner, Anja Waldmann, Aline Lindner, Torsten Tonn, Winfried S. Wels

    प्रकाशित 2017
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  2. 2
    Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival

    Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity a... द्वारा Sabrina Genßler, Michael C. Burger, Congcong Zhang, Sarah Oelsner, Iris Mildenberger, Marlies Wagner, Jörg Steinbach, Winfried S. Wels

    प्रकाशित 2015
    पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  3. 3
    Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma

    Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma द्वारा Sarah Oelsner, Miriam E. Friede, Congcong Zhang, Juliane Wagner, Susanne Badura, Peter Bader, Evelyn Ullrich, Oliver G. Ottmann, Hans Klingemann, Torsten Tonn, Winfried S. Wels

    प्रकाशित 2016
    पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  4. 4
    Genetically engineered CAR NK cells display selective cytotoxicity against FLT3‐positive B‐ALL and inhibit <i>in vivo</i> leukemia growth

    Genetically engineered CAR NK cells display selective cytotoxicity against FLT3‐positive B‐ALL and inhibit <i>in vivo</i> leukemia growth द्वारा Sarah Oelsner, Anja Waldmann, Arne Billmeier, Jasmin Röder, Aline Lindner, Evelyn Ullrich, Rolf Marschalek, Gianpietro Dotti, Gundram Jung, Ludger Große‐Hovest, Pranav Oberoi, Peter Bader, Winfried S. Wels

    प्रकाशित 2019
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  5. 5
    Chimeric antigen receptor‐engineered cytokine‐induced killer cells overcome treatment resistance of pre‐B‐cell acute lymphoblastic leukemia and enhance survival

    Chimeric antigen receptor‐engineered cytokine‐induced killer cells overcome treatment resistance of pre‐B‐cell acute lymphoblastic leukemia and enhance survival द्वारा Sarah Oelsner, Juliane Wagner, Miriam E. Friede, Verena Pfirrmann, Sabrina Genßler, Eva Rettinger, Christian J. Buchholz, Roman Pfeifer, Ralf Schubert, Oliver G. Ottmann, Evelyn Ullrich, Peter Bader, Winfried S. Wels

    प्रकाशित 2016
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:

खोज साधन: